P. A. Perez-mancera, A. R. Young, and M. Narita, Inside and out: the activities of senescence in cancer, Nat Rev Cancer, vol.14, pp.547-558, 2014.

S. Lee and C. A. Schmitt, The dynamic nature of senescence in cancer, Nat Cell Biol, vol.21, pp.94-101, 2019.

J. Bartkova, Z. Horejsi, and K. Koed, DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis, Nature, vol.434, pp.864-870, 2005.

M. Serrano, A. W. Lin, and M. E. Mccurrach, Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a, Cell, vol.88, pp.593-602, 1997.

C. Michaloglou, L. C. Vredeveld, and M. S. Soengas, BRAFE600-associated senescence-like cell cycle arrest of human naevi, Nature, vol.436, pp.720-724, 2005.

C. E. Burd, J. A. Sorrentino, and K. S. Clark, Monitoring tumorigenesis and senescence in vivo with a p16 (INK4a)-luciferase model, Cell, vol.152, pp.340-351, 2013.

N. E. Sharpless, N. Bardeesy, and K. H. Lee, Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis, Nature, vol.413, pp.86-91, 2001.

M. Bennecke, L. Kriegl, and M. Bajbouj, Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis, Cancer Cell, vol.18, pp.135-146, 2010.

Z. Chen, L. C. Trotman, and D. Shaffer, Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis, Nature, vol.436, pp.725-730, 2005.

M. Narita, S. Nunez, and E. Heard, Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence, Cell, vol.113, pp.703-716, 2003.

R. Zhang, W. Chen, and P. D. Adams, Molecular dissection of formation of senescence-associated heterochromatin foci, Mol Cell Biol, vol.27, pp.2343-2358, 2007.

F. Rodier, D. P. Munoz, and R. Teachenor, DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion, J Cell Sci, vol.124, pp.68-81, 2011.

A. Ivanov, J. Pawlikowski, and I. Manoharan, Lysosome-mediated processing of chromatin in senescence, J Cell Biol, vol.202, pp.129-143, 2013.

Z. Dou, K. Ghosh, and M. G. Vizioli, Cytoplasmic chromatin triggers inflammation in senescence and cancer, Nature, vol.550, pp.402-406, 2017.

T. Kuilman, C. Michaloglou, and L. C. Vredeveld, Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network, Cell, vol.133, pp.1019-1031, 2008.

N. Herranz, S. Gallage, and M. Mellone, mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype, Nat Cell Biol, vol.17, pp.1205-1217, 2015.

J. C. Acosta, A. Banito, and T. Wuestefeld, A complex secretory program orchestrated by the inflammasome controls paracrine senescence, Nat Cell Biol, vol.15, pp.978-990, 2013.

V. Krizhanovsky, Y. M. Dickins, and R. A. , Senescence of activated stellate cells limits liver fibrosis, Cell, vol.134, pp.657-667, 2008.

A. Mantovani, F. Marchesi, and A. Malesci, Tumourassociated macrophages as treatment targets in oncology, Nat Rev Clin Oncol, vol.14, pp.399-416, 2017.

W. Xue, L. Zender, and C. Miething, Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas, Nature, vol.445, pp.656-660, 2007.

I. B. Roninson, E. V. Broude, and B. D. Chang, If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells, Drug Resist Updat, vol.4, pp.303-313, 2001.

I. B. Roninson, Tumor cell senescence in cancer treatment, Cancer Res, vol.63, pp.2705-2715, 2003.

J. D. Leverson, D. Sampath, and A. J. Souers, Found in translation: how preclinical research is guiding the clinical development of the BCL2-selective inhibitor venetoclax, Cancer Discov, vol.7, pp.1376-1393, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01699792

C. M. Beausejour, A. Krtolica, and F. Galimi, Reversal of human cellular senescence: roles of the p53 and p16 pathways, Embo J, vol.22, pp.4212-4222, 2003.

T. Abbas and A. Dutta, p21 in cancer: intricate networks and multiple activities, Nat Rev Cancer, vol.9, pp.400-414, 2009.

J. Yu, Z. Wang, and K. W. Kinzler, PUMA mediates the apoptotic response to p53 in colorectal cancer cells, Proc Natl Acad Sci, vol.100, pp.1931-1936, 2003.

B. G. Childs, D. J. Baker, and J. L. Kirkland, Senescence and apoptosis: dueling or complementary cell fates?, EMBO Rep, vol.15, pp.1139-1153, 2014.

A. Vetillard, B. Jonchere, and M. Moreau, Akt inhibition improves irinotecan treatment and prevents cell emergence by switching the senescence response to apoptosis, Oncotarget, vol.6, pp.43342-43362, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01819855

T. S. Rai, J. J. Cole, and D. M. Nelson, HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia, Genes Dev, vol.28, pp.2712-2725, 2014.

Y. Yu, K. Schleich, and B. Yue, Targeting the senescence-overriding cooperative activity of structurally unrelated H3K9 demethylases in Melanoma, Cancer Cell, vol.33, p.785, 2018.

L. Duff, M. Gouju, J. Jonchere, and B. , Regulation of senescence escape by the cdk4-EZH2-AP2M1 pathway in response to chemotherapy, Cell Death Dis, vol.9, p.199, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01718563

C. A. Schmitt, J. S. Fridman, and M. Yang, A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy, Cell, vol.109, pp.335-346, 2002.

A. Krtolica, S. Parrinello, and S. Lockett, Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging, Proc Natl Acad Sci U S A, vol.98, pp.12072-12077, 2001.

S. De-carne-trecesson, Y. Guillemin, and A. Belanger, Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence